Dr. Kelly Clark has focused her career on issues of addictive disease, evidence informed behavioral health care, and payment reform. She is Chief Medical Officer of CleanSlate Centers, a multi-state medical group currently treating over 6,000 opioid addicted patients with medication and psychosocial care. CleanSlate has received a SAMHSA Science to Service Award for Office Based Opioid Treatment and a Center of Excellence Award from the Commonwealth of Pennsylvania. She is active on the Association of Managed Care Pharmacy’s Addiction Treatment Advisory Group; a member of the American Psychiatric Associations Integration Work Group; served on the writing committee of the Johns Hopkins Bloomberg School of Public Health’s recent policy document, “The Prescription Drug Epidemic: An Evidence Based Approach”; has serves as expert to the National Safety Council and the United States Comptroller General; has been a member of the Collaborative Care Research Network Steering Committee of the American Academy of Family Practice; and led the workgroup on Health Systems and Reimbursement at SAMHSA’s Buprenorphine Summit. She continues her work as a founding member of the Advisory Board of the National Rx Drug Abuse and Heroin Summit.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)